Kitahata Mari M, Dillingham Peter W, Chaiyakunapruk Nathorn, Buskin Susan E, Jones Jeffrey L, Harrington Robert D, Hooton Thomas M, Holmes King K
Department of Medicine, University of Washington, Harborview Medical Center, Box 359931, 325 9th Ave., Seattle, WA 98104, USA.
Clin Infect Dis. 2003 Mar 15;36(6):803-11. doi: 10.1086/368085. Epub 2003 Mar 4.
We conducted a prospective study of an electronic clinical reminder system in an academic medical center-based human immunodeficiency virus (HIV) specialty clinic. Published performance indicators were used to examine adherence to HIV practice guidelines before and after its implementation for 1204 patients. More than 90% of patients received CD4 cell count and HIV type 1 (HIV-1) RNA level monitoring every 3-6 months during both time periods, and approximately 80% of patients with a CD4 cell count nadir of <350 cells/mm(3) received highly active antiretroviral therapy. Patients were significantly more likely to receive prophylaxis against Mycobacterium avium complex (hazard ratio, 3.84; 95% confidence interval [CI], 1.58-9.31; P=.003), to undergo annual cervical carcinoma screening (OR, 2.09; 95% CI, 1.04-4.16; P=.04), and to undergo serological screening for Toxoplasma gondii (odds ratio [OR], 1.86; 95% CI, 1.05-3.27; P=.03) and syphilis infection (OR, 3.71; 95% CI, 2.37-5.81; P<.0001). HIV clinical reminders delivered at the time that HIV care is provided were associated with more timely initiation of recommended practices.
我们在一家以学术医疗中心为基础的人类免疫缺陷病毒(HIV)专科诊所对电子临床提醒系统进行了一项前瞻性研究。采用已发表的性能指标,对1204例患者在该系统实施前后对HIV诊疗指南的依从性进行了检查。在两个时间段内,超过90%的患者每3 - 6个月接受一次CD4细胞计数和1型人类免疫缺陷病毒(HIV - 1)RNA水平监测,并且CD4细胞计数最低点<350个细胞/mm³的患者中约80%接受了高效抗逆转录病毒治疗。患者更有可能接受鸟分枝杆菌复合体预防(风险比,3.84;95%置信区间[CI],1.58 - 9.31;P = 0.003)、接受年度宫颈癌筛查(比值比[OR],2.09;95% CI,1.04 - 4.16;P = 0.04)以及接受弓形虫血清学筛查(比值比[OR],1.86;95% CI,1.05 - 3.27;P = 0.03)和梅毒感染筛查(OR,3.71;95% CI,2.37 - 5.81;P < 0.0001)。在提供HIV治疗时发出的HIV临床提醒与更及时地启动推荐诊疗措施相关。